Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1145 results for "ranbaxy"

Sun Pharma Q4 profit at Rs 888 crore; Ranbaxy merger hurts
Times of India

Sun Pharma clocks net profit of ₹4,541 cr on sales of ₹27,...

In the year that saw Sun Pharmaceutical merge fellow drugmaker Ranbaxy into one entity, the company clocked consolidated net sales of ₹27,286 crore, and a net profit of ₹4,541 crore for the year ended March 31, 2015. Sealing the deal The ... Hindu Business Line, 20 hours ago
Ranbaxy integration hits Sun's performance Hindu Business Line, 20 hours ago

62 images for ranbaxy

Money Today, 23 hours ago
Times of India, 8 hours ago
Times of India, 8 hours ago
Reuters, 21 hours ago
First, 22 hours ago
First, 19 hours ago
Money Today, 2 weeks ago
India Infoline, 2 weeks ago
Sify, 2 weeks ago
Reuters, 2 weeks ago

Ranbaxy: A new challenge for Sun Pharma

Related to : Sun Pharmaceuticals Industries Ltd Sun Pharmaceuticals Industries Ltd BSE 29 May 15 | 12:00 AM 965.75 10 (1.05%) NSE 29 May 15 | 12:00 AM 966.10 11.3 (1.18%) Sun Pharma's results for the quarter ending March 2015 ...
 Smart Investor9 hours ago Integration challenges: Sun Pharma's next hurdle  INooz1 month ago

Ranbaxy effect playing on Sun Pharma's margins: Pros

Sarabjit Kour Nangra, VP- Research, Angel Broking, believes it to be the Ranbaxy effect. However, she says 14.5 percent is very low, because after consolidation she was looking at closer to 30 percent.
 Money Control23 hours ago

Sun Pharma Q4 profit seen up 9.7%, sales may rise 16%: Poll

D The bottomline is likely depend on overall sales and operating profit, Ranbaxy's forex figures (forex outflow in Q3 was Rs 132.6 crore) and currency impact in emerging markets. January-March quarter will have numbers from Sun Pharma as well as ...
 Moneycontrol.com2 days ago

DoP rejects Ranbaxy's review petition against fixation of ceiling prices of ciprofloxacin HCl injection

The Department of Pharmaceuticals (DoP) has rejected the review application filed by Ranbaxy Laboratories against the fixation/revision of ceiling prices of ciprofloxacin hydrochloride injection 200 mg/100 ml by the National Pharmaceutical Pricing ...
 PharmaBiz3 days ago
Money Control

Sun Pharma Announces Closure of Merger Deal with Ranbaxy

Sun Pharmaceutical Industries has begun the integration of Ranbaxy's business following the closure of its merger. The integration will focus on supporting strong growth. The merger has fortified Sun Pharma's position as the world's fifth largest ...
 PharmaAsia3 days ago Competition commission conditionally approves Sun-Ranbaxy deal  Lexology2 weeks ago Sun Pharma Falls After Ranbaxy Gets Slapped With Lawsuit  NDTV Profit2 weeks ago Sun Pharma, Ranbaxy and two R&D heads  Business Today India2 weeks ago

Ranbaxy introduces herpes drug in the US

 MyIris1 week ago IISC scientists bag Ranbaxy award  Times of India2 months ago
Financial Chronicle

Sun Pharma ready to spend $7b on M&A

Sun Pharmaceuticals Industries, emboldened by its takeover of domestic rival Ranbaxy Laboratories, is willing to spend as much as $7 billion on further acquisitions, bankers familiar with the generic drugmaker's strategy said. The just completed ...
 Financial Chronicle1 month ago BRENT CRUDE TURNS POSITIVE ON REPORTS OF IRAN SEIZING U.S. VESSEL -TRADERS  Reuters India1 month ago MAJORITY LEADER MCCONNELL STILL EXPECTS 'ROBUST' AMENDMENT PROCESS AS U.S. SENATE CONSIDERS IRAN REVIEW BILL  Reuters India1 month ago Sun Pharma scouting for more deals; may spend $7bn  Economic Times1 month ago

Daiichi will take a Rs2,450 crore charge on Ranbaxy investment

Ranbaxy has been facing serious issues with exports to the US, its most important market, since 2009. Photo: Pradeep Gaur/Mint Mumbai: Japanese drug maker Daiichi Sankyo Co. Ltd will take a significant hit on its books due to a one-time write-down ...
 Livemint.com1 month ago Daiichi salvages $3.2 billion from sunk Ranbaxy investment  DNA1 month ago Daiichi salvages $3.2 bn from sunk Ranbaxy investment  DNA1 month ago Daiichi Sankyo's disastrous India foray with hybrid model  Money Today1 month ago
Business Standard

Sun Pharma dips on listing of new shares

A 335 million equity shares issued pursuant to the scheme of amalgamation of Ranbaxy are listed w.e.f. April 17, 2015. SI Reporter | Mumbai April 17, 2015 Last Updated at 12:36 IST Shares of Sun Pharmaceuticals Industries were trading lower by 3% at Rs 1,061 ...
 Business Standard1 month ago Lifeline ends for Ranbaxy after half-a-century existence  DNA1 month ago Why This 54-Year-Old Company Stopped Trading Today  NDTV1 month ago Ranbaxy ends last trading day on bright note; surges over 5%  Business Standard1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranbaxy
Get updated on latest news & your favorite topics right in your inbox!
More     Less